On November 5, 2025, the Supreme Court heard oral argument in the consolidated tariff cases. This article addresses a few notable points made during the argument and examines the underpinnings of each. On balance, it appears the Supreme Court will not uphold the reciprocal and fentanyl tariffs imposed by the president under the International Emergency Economic Powers Act (“IEEPA”), though there are other more complicated means to a similar end. The Court’s decision is expected early this year.
Justice Barrett inquired of Solicitor General Sauer (“SG”) where there is any other place in the United States Code where the words “regulate importation” confer tariff-imposing authority. The SG noted it exists in the Trading with the Enemy Act (“TWEA”) as interpreted in Yoshida and IEEPA. In Yoshida, the Court of Customs and Patent Appeals held that President Nixon had the authority to impose a 10 percent import duty surcharge under TWEA’s authority to “regulate … importation.” Nevertheless, Yoshida made clear that each presidential proclamation must be evaluated on its own facts and circumstances. In that case, the measure issued under TWEA was temporary; it did not supplant the entire tariff scheme of Congress and did not apply to all imports, but only those imports already subject to tariffs. Yet, despite such limitations, the Yoshida court recognized that there was a broad grant of authority under TWEA, and said, “[t]hough such a broad grant may be considered unwise, or even dangerous, should it come into the hands of an unscrupulous, rampant president, willing to declare an emergency when none exists, the wisdom of a congressional delegation is not for us to decide.”
Continue reading “One-Way Ratchet and a Different Kind of Pastry: Trump Tariffs at the Supreme Court”